Glucosinolates and isothiocyanates in health and disease

Trends in Molecular Medicine

Volumn 18, Issue 6, 2012, Pages 337-347

  Dinkova Kostova, Albena T ^a,b   Kostov, Rumen V ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DITHIOCARBAMIC ACID; GLUCOSINOLATE; ISOTHIOCYANIC ACID; SULFORAPHANE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; BARRETT ESOPHAGUS; BEDTIME DOSAGE; BLADDER CANCER; BRAIN HEMORRHAGE; BRASSICACEAE; BREAST CANCER; BROCCOLI; CABBAGE; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CAULIFLOWER; CELL PROTECTION; COLORECTAL CANCER; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; EPIDERMOLYSIS BULLOSA; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; FOOD INTAKE; HAMSTER; HEART PROTECTION; HELICOBACTER INFECTION; HUMAN; HYDROLYSIS; IMMUNOMODULATION; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN HYPOXIA; NONHUMAN; PARKINSON DISEASE; PROSTATE CANCER; RADISH; RENAL PROTECTION; REPEATED DRUG DOSE; RETINA INJURY; REVIEW; SINGLE DRUG DOSE; SKIN FUNCTION; SPINAL CORD INJURY; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTICARCINOGENIC AGENTS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CELL TRANSFORMATION, NEOPLASTIC; CENTRAL NERVOUS SYSTEM; DIABETIC NEPHROPATHIES; GLUCOSINOLATES; HELICOBACTER INFECTIONS; HUMANS; ISOTHIOCYANATES; MODELS, ANIMAL; NEUROPROTECTIVE AGENTS; SKIN;

ANIMALIA; BRASSICA OLERACEA VAR. ITALICA; MAMMALIA;

EID: 84861875282     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.04.003     Document Type: Review

References (90)

1. Robiquet P.J., Boutron F. Sur la semence de moutarde. J. Pharm. Chim. 1831, 17:279-282.
2. Sønderby I.E., et al. Biosynthesis of glucosinolates - gene discovery and beyond. Trends Plant Sci. 2010, 15:283-290.
3. Koroleva O.A., et al. Glucosinolate-accumulating S-cells in Arabidopsis leaves and flower stalks undergo programmed cell death at early stages of differentiation. Plant J. 2010, 64:456-469.
4. Shapiro T.A., et al. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev. 1998, 7:1091-1100.
5. Getahun S.M., Chung F.L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomarkers Prev. 1999, 8:447-451.
6. Conaway C.C., et al. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 2000, 38:168-178.
7. Cramer J.M., Jeffery E.H. Sulforaphane absorption and excretion following ingestion of a semi-purified broccoli powder rich in glucoraphanin and broccoli sprouts in healthy men. Nutr. Cancer 2011, 63:196-201.
8. Clarke J.D., et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol. Res. 2011, 64:456-463.
9. Tang L., et al. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:938-944.
10. Zhang Y., et al. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:2399-2403.
11. Fahey J.W., et al. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10367-10372.
12. Zhang Y., et al. Spectroscopic quantitation of organic isothiocyanates by cyclocondensation with vicinal dithiols. Anal. Biochem. 1992, 205:100-107.
13. Gasper A.V., et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clin. Nutr. 2005, 82:1283-1291.
14. Egner P.A., et al. Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev. Res. (Phila.) 2011, 4:384-395.
15. Shapiro T.A., et al. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol. Biomarkers Prev 2001, 10:501-508.
16. Shapiro T.A., et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr. Cancer 2006, 55:53-62.
17. Kensler T.W., et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2605-2613.
18. Fahey J.W., et al. Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prev. Res. (Phila) 2012, 5:603-611.
19. Li F., et al. Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria. Br. J. Nutr. 2011, 106:408-416.
20. Wattenberg L.W. Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J. Natl. Cancer Inst. 1977, 58:395-398.
21. Graham S., et al. Diet in the epidemiology of cancer of the colon and rectum. J. Natl. Cancer Inst. 1978, 61:709-714.
22. Myzak M.C., et al. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood) 2007, 232:227-234.
23. Chen M.J., et al. Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane. Evid. Based Complement. Alternat. Med. 2012, 2012:415231.
24. Qazi A., et al. Anticancer activity of a broccoli derivative, sulforaphane, in Barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Transl. Oncol. 2010, 3:389-399.
25. Kanematsu S., et al. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol. Rep. 2011, 26:603-608.
26. Li Y., et al. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function. Nutr. Cancer 2011, 63:1151-1159.
27. Talalay P., et al. Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv. Enzyme Regul. 1978, 17:23-36.
28. Prochaska H.J., et al. Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:2394-2398.
29. Riedl M.A., et al. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin. Immunol. 2009, 130:244-251.
30. Harvey C.J., et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci. Transl. Med. 2011, 3:78ra32.
31. Navarro S.L., et al. Modulation of human serum glutathione S-transferase A1/2 concentration by cruciferous vegetables in a controlled feeding study is influenced by GSTM1 and GSTT1 genotypes. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2974-2978.
32. Dinkova-Kostova A.T., et al. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomarkers Prev. 2007, 16:847-851.
33. Thimmulappa R.K., et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002, 62:5196-5203.
34. Traka M., et al. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS ONE 2008, 3:e2568.
35. Taguchi K., et al. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011, 16:123-140.
36. Nguyen T., et al. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284:13291-13295.
37. McMahon M., et al. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18838-18843.
38. Hu C., et al. Modification of Keap1 cysteine residues by sulforaphane. Chem. Res. Toxicol. 2011, 24:515-521.
39. Kensler T.W., et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 2012, 33:101-107.
40. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr. Cancer Drug Targets 2006, 6:135-145.
41. Myzak M.C., et al. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J. 2006, 20:506-508.
42. Jackson S.J., et al. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vasc. Pharmacol. 2007, 46:77-84.
43. Hamsa T.P., et al. Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells. Drug Chem. Toxicol. 2011, 34:332-340.
44. Thejass P., Kuttan G. Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide 2007, 16:247-257.
45. Dey M., et al. Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem. Biol. 2010, 10:4.
46. Khor T.O., et al. Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm. Drug Dispos. 2006, 27:407-420.
47. Wu L., et al. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7094-7099.
48. Talalay P., et al. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17500-17505.
49. Brown K.K., et al. Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J. Biol. Chem. 2009, 284:32425-32433.
50. Healy Z.R., et al. Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention. Cancer Epidemiol. Biomarkers. Prev. 2011, 20:1516-1523.
51. Kim H.J., et al. Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells. J. Allergy Clin. Immunol. 2008, 121:1255-1261.
52. Senanayake G.V., et al. The dietary phase 2 protein inducer sulforaphane can normalize the kidney epigenome and improve blood pressure in hypertensive rats. Am. J. Hypertens. 2012, 25:229-235.
53. Mukherjee S., et al. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J. Agric. Food Chem. 2008, 56:609-617.
54. Tanito M., et al. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest. Ophthalmol. Vis. Sci. 2005, 46:979-987.
55. Kong L., et al. Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J. Neurochem. 2007, 101:1041-1052.
56. Zhao J., et al. Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. J. Neurosci. Res. 2005, 82:499-506.
57. Zhao J., et al. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J. Neurosci. 2007, 27:10240-10248.
58. Dash P.K., et al. Sulforaphane improves cognitive function administered following traumatic brain injury. Neurosci. Lett. 2009, 460:103-107.
59. Hong Y., et al. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol. Sin. 2010, 31:1421-1430.
60. Zhao X., et al. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 2007, 38:3280-3286.
61. Zhao X., et al. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J. Neurosci. 2009, 29:15819-15827.
62. Chen G., et al. Role of the Nrf2-ARE pathway in early brain injury after experimental subarachnoid hemorrhage. J. Neurosci. Res. 2011, 89:515-523.
63. Ping Z., et al. Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res. 2010, 1343:178-185.
64. Mao L., et al. Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury. J. Surg. Res. 2011, 170:e105-e115.
65. Wang X., et al. Activation of the nuclear factor e2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury. J. Neurotrauma 2012, 29:936-945.
66. Noyan-Ashraf M.H., et al. Dietary approach to decrease aging-related CNS inflammation. Nutr. Neurosci. 2005, 8:101-110.
67. Innamorato N.G., et al. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 2008, 181:680-689.
68. Jazwa A., et al. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid. Redox Signal. 2011, 14:2347-2360.
69. Kim D., et al. NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14851-14856.
70. Toyama T., et al. Isothiocyanates reduce mercury accumulation via an Nrf2-dependent mechanism during exposure of mice to methylmercury. Environ. Health Perspect. 2011, 119:1117-1122.
71. Zheng H., et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011, 60:3055-3066.
72. Negi G., et al. Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr. Neurovasc. Res. 2011, 8:294-304.
73. Kerns M.L., et al. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14460-14465.
74. Fahey J.W., et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7610-7615.
75. Yanaka A., et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev. Res. (Phila.) 2009, 2:353-360.
76. Morse M.A., et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res. 1989, 49:549-553.
77. Morse M.A., et al. Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Lett. 1992, 62:77-81.
78. Conaway C.C., et al. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 2005, 65:8548-8557.
79. Stoner G.D., et al. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res. 1991, 51:2063-2068.
80. Chung F.L., et al. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000, 21:2287-2291.
81. Khor T.O., et al. Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC). Mol. Carcinog. 2008, 47:321-325.
82. Zhang Y., et al. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3147-3150.
83. Kuroiwa Y., et al. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett. 2006, 241:275-280.
84. Gills J.J., et al. Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett. 2006, 236:72-79.
85. Xu C., et al. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 2006, 66:8293-8296.
86. Singh S.V., et al. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2009, 69:2117-2125.
87. Munday R., et al. Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008, 68:1593-1600.
88. Dinkova-Kostova A.T., et al. Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett. 2006, 240:243-252.
89. Keum Y.S., et al. Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway. Pharm. Res. 2009, 26:2324-2331.
90. Dinkova-Kostova A.T., et al. Dietary glucoraphanin-rich broccoli sprout extracts protect against UV radiation-induced skin carcinogenesis in SKH-1 hairless mice. Photochem. Photobiol. Sci. 2010, 9:597-600.